These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 18628721)
1. Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status. Shields CL; Bianciotto C; Rudich D; Materin MA; Ganguly A; Shields JA Retina; 2008 Oct; 28(9):1289-95. PubMed ID: 18628721 [TBL] [Abstract][Full Text] [Related]
2. Small choroidal melanoma with chromosome 3 monosomy on fine-needle aspiration biopsy. Shields CL; Materin MA; Teixeira L; Mashayekhi A; Ganguly A; Shields JA Ophthalmology; 2007 Oct; 114(10):1919-24. PubMed ID: 17698199 [TBL] [Abstract][Full Text] [Related]
3. Ocular response of choroidal melanoma with monosomy 3 versus disomy 3 after iodine-125 brachytherapy. Marathe OS; Wu J; Lee SP; Yu F; Burgess BL; Leu M; Straatsma BR; McCannel TA Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1046-8. PubMed ID: 20932685 [TBL] [Abstract][Full Text] [Related]
4. Cytogenetics of uveal melanoma: a 7-year clinical experience. Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643 [TBL] [Abstract][Full Text] [Related]
5. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship. Shields CL; Ganguly A; Materin MA; Teixeira L; Mashayekhi A; Swanson LA; Marr BP; Shields JA Arch Ophthalmol; 2007 Aug; 125(8):1017-24. PubMed ID: 17698747 [TBL] [Abstract][Full Text] [Related]
6. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss. Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972 [TBL] [Abstract][Full Text] [Related]
7. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type. Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742 [TBL] [Abstract][Full Text] [Related]
8. Fluorescent in situ hybridization for monosomy 3 via 30-gauge fine-needle aspiration biopsy of choroidal melanoma in vivo. Young TA; Rao NP; Glasgow BJ; Moral JN; Straatsma BR Ophthalmology; 2007 Jan; 114(1):142-6. PubMed ID: 17097737 [TBL] [Abstract][Full Text] [Related]
9. Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma. Triozzi PL; Elson P; Aldrich W; Achberger S; Tubbs R; Biscotti CV; Singh AD Melanoma Res; 2013 Feb; 23(1):1-7. PubMed ID: 23196330 [TBL] [Abstract][Full Text] [Related]
10. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992 [TBL] [Abstract][Full Text] [Related]
11. Tumor-related lipid exudation after plaque radiotherapy of choroidal melanoma: the role of Bruch's membrane rupture. Mashayekhi A; Tuncer S; Shields CL; Shields JA Ophthalmology; 2010 May; 117(5):1013-23. PubMed ID: 20097428 [TBL] [Abstract][Full Text] [Related]
12. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma. Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA Ophthalmology; 2010 May; 117(5):1005-12. PubMed ID: 20079924 [TBL] [Abstract][Full Text] [Related]
13. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063 [TBL] [Abstract][Full Text] [Related]
14. Chromosome 3 intratumor heterogeneity in uveal melanoma. Mensink HW; Vaarwater J; Kiliç E; Naus NC; Mooy N; Luyten G; Brüggenwirth HT; Paridaens D; de Klein A Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):500-4. PubMed ID: 18824727 [TBL] [Abstract][Full Text] [Related]
15. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Tschentscher F; Hüsing J; Hölter T; Kruse E; Dresen IG; Jöckel KH; Anastassiou G; Schilling H; Bornfeld N; Horsthemke B; Lohmann DR; Zeschnigk M Cancer Res; 2003 May; 63(10):2578-84. PubMed ID: 12750282 [TBL] [Abstract][Full Text] [Related]
16. Clinical and cytogenetic analyses in uveal melanoma. Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076 [TBL] [Abstract][Full Text] [Related]
17. Does choroidal melanoma regression correlate with chromosome 3 loss after ruthenium brachytherapy? Chiam PJ; Coupland SE; Kalirai H; Groenewald C; Heimann H; Damato BE Br J Ophthalmol; 2014 Jul; 98(7):967-71. PubMed ID: 24518077 [TBL] [Abstract][Full Text] [Related]
18. Novel cell lines derived by long-term culture of primary uveal melanomas. Nareyeck G; Zeschnigk M; Bornfeld N; Anastassiou G Ophthalmologica; 2009; 223(3):196-201. PubMed ID: 19212147 [TBL] [Abstract][Full Text] [Related]
19. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases. Shields CL; Ganguly A; Materin MA; Teixeira L; Mashayekhi A; Swanson LA; Marr BP; Shields JA Trans Am Ophthalmol Soc; 2007; 105():43-52; discussion 52-3. PubMed ID: 18427593 [TBL] [Abstract][Full Text] [Related]